Eli Lilly & Co. Stock Slips 3.6%, Underperforms Peers

This article was automatically generated by Dow Jones using technology from Automated Insights.

Shares of Eli Lilly & Co. slipped 3.6% to $1,189.41 on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index remaining mostly unchanged at 7,675.70 and the Dow Jones Industrial Average falling 0.2% to 53,463.88.

This was the stock's third consecutive day of losses.

Eli Lilly & Co. closed 8.0% below its 52-week high of $1,292.65, which the company reached on August 19th.

The stock underperformed when compared to some of its peers, as Johnson & Johnson fell 1.1% to $270.00, Pfizer Inc. fell 0.9% to $28.30, and AbbVie Inc. fell 1.09% to $262.90.

Trading volume totaled 3.0 million, compared to the 50-day average of 2.8 million.

Data source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

August 26, 2026 16:34 ET (20:34 GMT)